ProQR Therapeutics PRQR
NASDAQ PRQR
$1.37 -0.01 (-0.72%)
At close: Oct 21, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Total Liabilities (2013 - 2026)

Updated

ProQR Therapeutics (PRQR) posted Total Liabilities of $62.86 million for the quarter ended Jun 30, 2026, down 21.3% from $79.86 million a year earlier and down 12.6% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Total Liabilities (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, ProQR Therapeutics' Total Liabilities came in at $71.61 million, down 16.7% from the prior year.

  • Annual Total Liabilities has declined for four consecutive years, though with a five-year compound annual growth rate of 8.3% (years ended Dec 2020 to Dec 2025).
  • In prior years, ProQR Therapeutics' Total Liabilities was $85.94 million in the year ended Dec 31, 2024 (-17.7%), $104.38 million in the year ended Dec 31, 2023 (-5.4%), $110.29 million in the year ended Dec 31, 2022 (-2.4%) and $112.98 million in the year ended Dec 31, 2021 (+134.6%).
  • The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Total Liabilities since the quarter ended Sep 30, 2022.
  • On a year-over-year basis, Total Liabilities has declined in each of the last 11 quarters, with an average decline of 14.8% over the last eight quarters.
  • The strongest year-over-year quarter for Total Liabilities in the past five years was the quarter ended Dec 31, 2021, with growth of 117.1%; the weakest was the quarter ended Sep 30, 2022, with a decline of 31.8%.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $71.93 million (quarter ended Mar 31, 2026), $73.78 million (quarter ended Dec 31, 2025) and $78.65 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 116.09 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 141.05 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 65.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 37.53 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 115.64 Bn
10 ProQR Therapeutics 145.89 Mn -314.77 Mn - 61.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 61.77 Mn
Mar 31, 2026 70.41 Mn
Dec 31, 2025 74.46 Mn
Sep 30, 2025 78.93 Mn
Jun 30, 2025 82.74 Mn
Mar 31, 2025 78.75 Mn
Dec 31, 2024 82.62 Mn
Sep 30, 2024 91.45 Mn
Jun 30, 2024 91.23 Mn
Mar 31, 2024 96.13 Mn
Dec 31, 2023 106.80 Mn
Sep 30, 2023 101.08 Mn
Jun 30, 2023 104.87 Mn
Mar 31, 2023 108.30 Mn
Dec 31, 2022 111.55 Mn
Sep 30, 2022 52.80 Mn
Jun 30, 2022 93.68 Mn
Mar 31, 2022 99.12 Mn
Dec 31, 2021 108.12 Mn
Sep 30, 2021 78.09 Mn
API Access

ProQR Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=PRQR&period=max&api_key=YOUR_API_KEY